BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Lynparza Hits the Mark Again in a Late-Stage Trial, This Time in Prostate Cancer

  AstraZeneca and Merck plan on seeking regulatory approval for Lynparza as a treatment for a subset of prostate cancer patients based on the Phase III PROfound data.

  August 7, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Adaptive Biotechnologies to Triple Seattle Footprint with New HQ

  Adaptive Biotechnologies, based in Seattle, announced plans to lease a new corporate headquarters. They signed a 12-year, full-building, 100,000-square foot lease with Alexandria Real Estate Equities.

  August 7, 2019

   · 

  2 min read

   · 

  Mark Terry
• Business

  Retrophin Reports Second Quarter 2019 Financial Results

  Retrophin, Inc. reported its second quarter 2019 financial results and provided a corporate update.

  August 7, 2019

   · 

  15 min read
• Business

  Todos Medical Appoints Dr. Jorge Leon as Medical Advisor

  Dr. Leon previously played a key role in establishing and leading Quest Diagnostics’ Molecular Diagnostics laboratories.

  August 7, 2019

   · 

  7 min read
• BioMidwest

  Esperion to Present at the BTIG Biotechnology Conference

  Esperion announced that the company will participate in a lipid panel discussion with investors at the BTIG Biotechnology Conference in New York, NY on Monday, August 12, 2019 at 11:00 a.m. Eastern Time.

  August 7, 2019

   · 

  6 min read
• Job Trends

  Blood Clotting Proteins in Urine Discovered as Biomarkers of Lupus Nephritis

  Finding Could Lead to Better Clinical Disease Monitoring

  August 7, 2019

   · 

  3 min read
• Deals

  Pharma study: How mature processes only last until the next audit

  Big Data falls short - the consulting company MAIN5 presents study “Pharma Insights 2019"

  August 7, 2019

   · 

  3 min read
• Deals

  NOXXON Announces A Capital Increase Of €1 Million Through A Private Placement Of Shares Without Warrants

  NOXXON Pharma N.V. announced that following discussions with investors it has received letters of intent and binding commitments for long-term investment of €1 million through a private placement plus additional commitment for a future private placement.

  August 7, 2019

   · 

  3 min read
• Business

  Medigene AG: Medigene reports financial & business results for the first six months of 2019

  Conference call and webcast, August 07, 2019 at 3:00 pm CET, 9:00 am EST

  August 7, 2019

   · 

  9 min read
• Policy

  Quanta Begins Study in US to support FDA Submission

  Quanta Dialysis Technologies Ltd, a British medical technology company developing a personal haemodialysis system for patient use in the clinic and the home, announces that it has begun human factors testing of SC+ in the United States with Design Science, a leading specialist in medical device usability.

  August 7, 2019

   · 

  1 min read